Gyre Therapeutics Inc.
Biotechnology
Healthcare
GYRE
103 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.42
52 week high
16.80
high
7.55
52 week low
0.00
previous Close
7.47
P/E ratio
market cap
738 M
div yield
0
net incoming
442 K
-92.02 %
net profit margin
1.65 %
-23.00 %
operating incoming
2.17 M
-4.49 %
net change in cash
21.45 M
563.55 %
cash on hand
36.49 M
142.55 %
cost of revenue
1.15 M
28.75 %
top